Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NT-proBNP”

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT07306949
What this trial is testing

Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association With Cardiac Biomarkers

Who this might be right for
Transthyretin-type Cardiac Amyloidosis
Alexion Pharmaceuticals, Inc. 200
Post-approval studies (Phase 4)Study completedNCT00498472
What this trial is testing

NT-proBNP in the Optimization of Treatment After Recent Acute Heart Failure Trial

Who this might be right for
Acute Heart Failure
Università degli Studi di Brescia 330
Large-scale testing (Phase 3)Study completedNCT04420481
What this trial is testing

Growth Hormone in Ischemic Heart Failure

Who this might be right for
Heart Failure, SystolicIschemic Heart Disease Chronic
Göteborg University 37
Not applicableUnknownNCT01442350
What this trial is testing

Myocardial Affectation in Patients With Fabry Disease Without Phenotypic Manifestation. Diagnostic Value of Biomarkers

Who this might be right for
Fabry Disease, Cardiac VariantRight Ventricular Hypertrophy
Francisco Marín Ortuño 120
Post-approval studies (Phase 4)UnknownNCT00601679
What this trial is testing

Improvement of Patients With Chronic Heart Failure Using NT-proBNP

Who this might be right for
Congestive Heart Failure
Unity Health Toronto 400
Large-scale testing (Phase 3)Study completedNCT03988634
What this trial is testing

Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)

Who this might be right for
Heart Failure With Preserved Ejection Fraction (HFpEF)
Novartis Pharmaceuticals 467
Not applicableStudy completedNCT00143793
What this trial is testing

NT-proBNP and New Biomarkers in Patients With Dyspnea and/or Peripheral Edema

Who this might be right for
DyspneaPeripheral Edema
Universitätsmedizin Mannheim 400
Post-approval studies (Phase 4)UnknownNCT05164653
What this trial is testing

Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER)

Who this might be right for
Heart Failure
Saga University 400
Large-scale testing (Phase 3)Study completedNCT00562952
What this trial is testing

Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients

Who this might be right for
Diabetes MellitusHeart FailureCoronary Artery Disease
Medical University of Vienna 300
Not applicableStudy completedNCT03068364
What this trial is testing

Biological and Electrocardiographic Biomarkers for Risk Stratification in Hypertension.

Who this might be right for
Hypertension
Hospices Civils de Lyon 1,600
Not applicableNot Yet RecruitingNCT07762521
What this trial is testing

Bedside NT-proBNP Monitoring in Acute Heart Failure

Who this might be right for
Acute Decompensated Heart Failure (ADHF)
Mao Chen 50
Not applicableStudy completedNCT04677309
What this trial is testing

Lung Ultrasound to Assess Aeration Loss After Lung Resection Surgery

Who this might be right for
Lung NeoplasmLung CancerLung Resection Surgery+5 more
Ana Broseta Lleó 32
Not applicableUnknownNCT03857022
What this trial is testing

Evaluate the Effects of EECP in Patients With Heart Failure

Who this might be right for
Heart Failure
National Taiwan University Hospital 40
Not applicableUnknownNCT00519961
What this trial is testing

A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery

Who this might be right for
Peripheral Vascular Disease
Hoffmann-La Roche 1,800
Not applicableLooking for participantsNCT07483879
What this trial is testing

Biomarkers of Acute Organ Injury in Pediatric Newly Diagnosed Type 1 Diabetes

Who this might be right for
Type 1 Diabetes MellitusDiabetic Ketoacidosis
Aristotle University Of Thessaloniki 45
Post-approval studies (Phase 4)Study completedNCT04023227
What this trial is testing

Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC

Who this might be right for
Chagas DiseaseHeart Failure
Novartis Pharmaceuticals 922
Not applicableNot Yet RecruitingNCT07754084
What this trial is testing

Comprehensive Clinical Prediction Rule for Acute Heart Failure

Who this might be right for
Acute Heart Failure (AHF)
Chinese University of Hong Kong 560
Not applicableStudy completedNCT06145347
What this trial is testing

Correlation Between Preoperative NT-proBNP and Postoperative AKI

Who this might be right for
Acute Kidney Injury
Xijing Hospital 629
Not applicableLooking for participantsNCT03878706
What this trial is testing

The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination

Who this might be right for
Diabetes Mellitus, Type 2
University of Athens 240
Not applicableUnknownNCT00426374
What this trial is testing

Assessment of Asymptomatic Heart Disease in Children With HIV

Who this might be right for
HIV Infections
Hadassah Medical Organization
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation